{
  "zip": "K1C 1G5",
  "sector": "Healthcare",
  "fullTimeEmployees": 31,
  "longBusinessSummary": "Tetra Bio-Pharma Inc., a development stage biopharmaceutical company, engages development of cannabinoid-based medicines. It develops drugs for chronic pain, which includes SERENITY for cancer cachexia, which is clinical phase 2; REBORN, drug for breakthrough pain, which is in clinical phase 2; and PLENITUDE for advanced cancer pain, which is clinical phase 1. The company also develops PPP003, drug for painful dry eye and uveitis pain, which is in clinical phase 1; and HCC011 for hepatocellular carcinoma.It has collaboration agreements with Aphria Inc.; IntelGenx Corp.; Panag Pharma Inc.; the University of New Brunswick; and Ovensa Inc. The company also has a co-development partnership with Storz & Bickel for the treatment of fibromyalgia. The company was formerly known as GrowPros Cannabis Ventures Inc. and changed its name to Tetra Bio-Pharma Inc. in September 2016. Tetra Bio-Pharma Inc. is headquartered in Orleans, Canada.",
  "city": "OrlÃ©ans",
  "phone": "343 780 2020",
  "state": "ON",
  "country": "Canada",
  "companyOfficers": [],
  "website": "http://www.tetrabiopharma.com",
  "maxAge": 1,
  "address1": "2742 St. Joseph Boulevard",
  "industry": "Biotechnology",
  "address2": "Unit 200",
  "previousClose": 0.1568,
  "regularMarketOpen": 0.144,
  "twoHundredDayAverage": 0.14215107,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.1641,
  "navPrice": null,
  "averageDailyVolume10Day": 218087,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.1568,
  "fiftyDayAverage": 0.14884242,
  "trailingAnnualDividendRate": null,
  "open": 0.144,
  "averageVolume10days": 218087,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 2.012541,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.144,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 188428,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 44943612,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 120547,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.144,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 188428,
  "fiftyTwoWeekHigh": 0.6045,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.094,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.1641,
  "exchange": "PNK",
  "shortName": "TETRA BIO PHARMA INC",
  "longName": "Tetra Bio-Pharma Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "TBPMF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_266261407",
  "uuid": "16464661-e18c-37c3-9290-bbb0eab44b5d",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 281832992,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 0.089,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1575072000,
  "heldPercentInstitutions": 0.00294,
  "netIncomeToCommon": null,
  "trailingEps": -0.029,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 1.7404494,
  "heldPercentInsiders": 0.13408,
  "nextFiscalYearEnd": 1638230400,
  "mostRecentQuarter": 1598832000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 244126222,
  "enterpriseValue": 44191352,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1403481600,
  "lastSplitFactor": "1:2",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.144,
  "logo_url": "https://logo.clearbit.com/tetrabiopharma.com"
}